Orange Book product · Generic (ANDA)
BRIVARACETAM
BRIVARACETAM
At a glance
Feb 23, 2026
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 23, 2026
4 mo ago
Today
Pharmaceutical detail
Active ingredient
BRIVARACETAM
Strength
10MG/ML
Dosage form
SOLUTION
Route
ORAL
TE code
AA
Application
ANDA 218494
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BRIVARACETAM
- 2016BRIVIACTBrand (NDA)
NDA 205837 · UCB INC
- 2016BRIVIACTBrand (NDA)
NDA 205838 · UCB INC
- 2016BRIVIACTBrand (NDA)
NDA 205836 · UCB INC
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 218249 · HAINAN POLY
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 214880 · MICRO LABS
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 214924 · MSN
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 219772 · ALKEM LABS LTD
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 220164 · LUPIN
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 220385 · REGCON HOLDINGS
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 214875 · APOTEX
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 220470 · CENTAUR PHARMS PVT
- 2026BRIVARACETAMGeneric (ANDA)
ANDA 214922 · MSN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
